Stocktoria
Acurx Pharmaceuticals, Inc. ACXP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-06-25
Acurx Pharmaceuticals, Inc. statistics & valuation
Market cap$6.5M
P / B1.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -103.6% | -365.6% | -189.1% | -129.0% | -96.2% |
| Return on equity | -151.2% | -2292.7% | -312.4% | -165.3% | -102.7% |
| Current ratio | — | 1.19 | 2.53 | 4.55 | 15.71 |
Source: SEC EDGAR filings · CIK 0001736243 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.